Sopharma AD (BUL:SFA)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 1.880
+0.010 (0.53%)
At close: May 29, 2026
Sopharma AD Cash Flow Statement
Financials in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 154.8 | 133.52 | 76.31 | 95.98 | 71.12 | 89.5 |
Depreciation & Amortization | 77.84 | 74.43 | 55.15 | 52.06 | 48.86 | 50.62 |
Other Amortization | 4.6 | 4.6 | 4.2 | 3.9 | 3.37 | 2.67 |
Asset Writedown & Restructuring Costs | 0.29 | 0.29 | 0.26 | - | - | - |
Other Operating Activities | -155.86 | -194.29 | -59.18 | -106.91 | -13.27 | -218.75 |
Operating Cash Flow | 81.66 | 18.55 | 76.73 | 45.03 | 110.08 | -75.96 |
Operating Cash Flow Growth | -59.83% | -75.82% | 70.39% | -59.09% | - | - |
Capital Expenditures | -44.43 | -45 | -33.88 | -24.39 | -19.35 | -20.35 |
Sale of Property, Plant & Equipment | 1.47 | 1.27 | 2.87 | 15.03 | 1.92 | 1.06 |
Cash Acquisitions | -1.17 | -1.32 | -14.57 | -9.35 | -2.34 | -2.34 |
Divestitures | 11.09 | 11.09 | -0.24 | - | 0.4 | -1.15 |
Sale (Purchase) of Intangibles | -104.73 | -97.84 | -87.51 | -18.9 | -4.31 | -6.76 |
Sale (Purchase) of Real Estate | 0.35 | 0.35 | - | - | - | 1.95 |
Investment in Securities | 8.12 | 4.81 | -7.83 | -37.95 | -16.53 | -40.89 |
Other Investing Activities | -0.54 | -0.34 | 58.12 | 17.4 | -21.45 | -2.35 |
Investing Cash Flow | -123.36 | -120.65 | -88.09 | -62.85 | -63.61 | -68.07 |
Short-Term Debt Issued | - | 118.34 | 34.37 | 44.07 | 30.96 | 213.46 |
Long-Term Debt Issued | - | 43.02 | 143.41 | 36.57 | 2.16 | 16.83 |
Total Debt Issued | 106.54 | 161.36 | 177.78 | 80.64 | 33.13 | 230.29 |
Short-Term Debt Repaid | - | -6.48 | -34.16 | -1.19 | -59.07 | -27.15 |
Long-Term Debt Repaid | - | -64.67 | -88.8 | -30.34 | -36.11 | -39.88 |
Total Debt Repaid | -104.99 | -71.15 | -122.96 | -31.52 | -95.18 | -67.03 |
Net Debt Issued (Repaid) | 1.55 | 90.21 | 54.82 | 49.11 | -62.06 | 163.27 |
Issuance of Common Stock | 72.81 | 65.55 | 32.64 | 156.08 | - | - |
Repurchase of Common Stock | -0 | -0 | -0.01 | -5.25 | -1.92 | -16.63 |
Common Dividends Paid | -44.08 | -13.6 | -168.44 | -71.89 | -0.01 | -0.06 |
Other Financing Activities | 3.37 | -4.08 | -0.9 | -1.21 | -0.36 | 10.03 |
Financing Cash Flow | 33.66 | 138.08 | -81.88 | 126.84 | -64.34 | 156.61 |
Net Cash Flow | -8.05 | 35.97 | -93.25 | 109.02 | -17.87 | 12.58 |
Free Cash Flow | 37.24 | -26.45 | 42.85 | 20.64 | 90.74 | -96.31 |
Free Cash Flow Growth | -77.86% | - | 107.57% | -77.25% | - | - |
Free Cash Flow Margin | 1.38% | -1.00% | 1.99% | 1.09% | 5.43% | -5.98% |
Free Cash Flow Per Share | 0.07 | -0.08 | 0.09 | 0.05 | 0.24 | -0.26 |
Cash Interest Paid | 19.37 | 19.37 | 14.81 | 10.61 | 6.39 | 9.16 |
Cash Income Tax Paid | 120.6 | 120.6 | 73.18 | 13.42 | 9.86 | 7.89 |
Levered Free Cash Flow | - | -182.05 | -119.73 | 123.25 | 103.77 | 85.16 |
Unlevered Free Cash Flow | - | -168.61 | -111.64 | 130.12 | 107.53 | 91.9 |